130 related articles for article (PubMed ID: 24365420)
1. Neurologic complications of bone marrow transplantation.
Rodriguez TE
Handb Clin Neurol; 2014; 121():1295-304. PubMed ID: 24365420
[TBL] [Abstract][Full Text] [Related]
2. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
[TBL] [Abstract][Full Text] [Related]
3. Early central nervous system complications after reduced-intensity stem cell transplantation.
Kishi Y; Miyakoshi S; Kami M; Ikeda M; Katayama Y; Murashige N; Kusumi E; Yuji K; Kobayashi K; Kato D; Hamaki T; Matsumura T; Kim SW; Morinaga S; Mori S; Kanemaru M; Hayashi T; Takaue Y; Taniguchi S;
Biol Blood Marrow Transplant; 2004 Aug; 10(8):561-8. PubMed ID: 15282534
[TBL] [Abstract][Full Text] [Related]
4. Neurologic complications of bone marrow, stem cell, and organ transplantation in patients with cancer.
Rosenfeld MR; Pruitt A
Semin Oncol; 2006 Jun; 33(3):352-61. PubMed ID: 16769425
[TBL] [Abstract][Full Text] [Related]
5. Neurologic complications of bone marrow transplantation.
Davis DG; Patchell RA
Neurol Clin; 1988 May; 6(2):377-87. PubMed ID: 3047547
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
Nagler A; Slavin S; Varadi G; Naparstek E; Samuel S; Or R
Bone Marrow Transplant; 2000 May; 25(10):1021-8. PubMed ID: 10828860
[TBL] [Abstract][Full Text] [Related]
7. [Neurological complications of transplantation].
Martínez-Hernández E; Rosenfeld MR; Pruitt A; Dalmau J
Neurologia; 2008; 23(6):373-86. PubMed ID: 18597192
[TBL] [Abstract][Full Text] [Related]
8. Life-threatening neurological complications after bone marrow transplantation in children.
Uckan D; Cetin M; Yigitkanli I; Tezcan I; Tuncer M; Karasimav D; Oguz KK; Topçu M
Bone Marrow Transplant; 2005 Jan; 35(1):71-6. PubMed ID: 15531898
[TBL] [Abstract][Full Text] [Related]
9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
10. Neurologic complications of hematopoietic cell transplantation.
Saiz A; Graus F
Semin Neurol; 2010 Jul; 30(3):287-95. PubMed ID: 20577935
[TBL] [Abstract][Full Text] [Related]
11. Neurological complications of hematopoietic cell transplantation.
Saiz A; Graus F
Semin Neurol; 2004 Dec; 24(4):427-34. PubMed ID: 15637654
[TBL] [Abstract][Full Text] [Related]
12. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
[TBL] [Abstract][Full Text] [Related]
13. Neurologic complications of intestinal transplantation.
Stracciari A; Guarino M
Handb Clin Neurol; 2014; 121():1267-76. PubMed ID: 24365418
[TBL] [Abstract][Full Text] [Related]
14. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
Michallet M; Dhedin N; Michallet AS
Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
[TBL] [Abstract][Full Text] [Related]
15. Neurologic aspects of heart transplantation.
Heroux A; Pamboukian SV
Handb Clin Neurol; 2014; 121():1229-36. PubMed ID: 24365414
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G
Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666
[TBL] [Abstract][Full Text] [Related]
17. Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donors.
Lee KH; Choi SJ; Lee JH; Lee JH; Kim DY; Seol M; Lee YS; Kang YA; Jeon M; Yun SC; Joo YD; Lee WS; Kang MJ; Kim H; Park JH; Bae SH; Ryoo HM; Kim MK; Hyun MS
Am J Hematol; 2011 May; 86(5):399-405. PubMed ID: 21523798
[TBL] [Abstract][Full Text] [Related]
18. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
[TBL] [Abstract][Full Text] [Related]
20. Neurologic complications after allogeneic bone marrow transplantation.
Gallardo D; Ferrà C; Berlanga JJ; Banda ED; Ponce C; Salar A; Alonso E; Espanñol I; Riu C; Grañena A
Bone Marrow Transplant; 1996 Dec; 18(6):1135-9. PubMed ID: 8971384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
